 | This article needs additional citations for verification .(March 2020) |
The Central European Diabetes Association (CEDA) is an international medical and scientific association. CEDA was founded in Vienna, Austria, in 1969 as Federation of International Danube Symposia on Diabetes mellitus (FID). After the inclusion of members from the Baltic States, the name of the association was changed to Central European Diabetes Association in 2006.
During the time of the Cold War, CEDA/FID congresses aimed to serve as a bridge across the Iron Curtain. This was possible because Austria was politically neutral and not a member of NATO, so that it was more easily accessible for diabetologists from Eastern Europe and especially from countries belonging to the Warsaw Pact. Everything started with the idea to bring diabetologists from East and West together despite all political borders to share scientific data and discuss clinical practice. This initiative turned out to be very successful. Currently, CEDA’s mission is to promote the exchange of theoretical and practical knowledge and to align clinical standards with the aim to improve the management of diabetes mellitus and its complications. Despite the geographical proximity, it often appears that the distance between the countries of Central Europe is still bigger than commonly assumed after having been politically separated for decades. Therefore, CEDA contributes to close the gap by exchanging knowledge in the field of diabetology.
Since 1969, CEDA has organized international congresses, at first every two years, since 2003 annually. In addition, regional and international symposia with speakers from different CEDA countries take place. The CEDA congresses alternate between countries in Central and Eastern Europe.
The official journal of CEDA is the Medline-listed Diabetes, Stoffwechsel und Herz (Diabetes, Metabolism and Heart) that is published six times per year by Kirchheim Verlag (Mainz, Germany). [1] This journal also publishes the CEDA congress abstracts.
After the political revolutions in 1989, the mission of CEDA is to provide high-quality medical and scientific education related to diabetes in Central and Eastern Europe. This includes the aim to harmonize clinical standards between CEDA countries. Another aim of CEDA consists of giving younger diabetologists the opportunity to present and discuss their research data and to facilitate the contact with international diabetes experts. Initially, German was the official congress language. This has almost been exclusively changed to English for the scientific discussions in order to attract in particular younger scientists and physicians to CEDA and to international diabetes research and practice. In order to promote this exchange, CEDA awards travel grants for its congresses and for internships enabling visits to other diabetes centers in Central Europe for the duration of up to several months.
The board consists of 10 diabetologists from different CEDA countries. The current president (2022) is Prof. Péter Kempler (Semmelweis University, Budapest, Hungary), Prof. Thomas Stulnig (Hietzing Hospital with Neurological Centre Rosenhügel, Vienna, Austria) is past-president, Prof. Nebojsa Lalic (University Clinical Center of Serbia, Belgrade, Serbia) is vice-president and Prof. Christian Herder (German Diabetes Center, Düsseldorf, Germany) serves as general-secretary. [2] The CEDA main office is located in Vienna, Austria. CEDA currently lists 480 members.
The International Ornithologists' Union (IOU) is an international organization for the promotion of ornithology. It links basic and applied research and nurtures education and outreach activities. Specifically, the IOU organizes and funds global congresses on ornithology at regular intervals, sets up and supports commissions and committees on various aspects of avian biology and conservation, and initiates and backs other international ornithological activities with specific aims consistent with its own mission and goal. It discloses the names and professional affiliations of its members on its website to encourage international collaboration and networking. The IOU acts as the Ornithology Section of the IUBS.
AIDA is a freeware computer program that permits the interactive simulation of plasma insulin and blood glucose profiles for demonstration, teaching, self-learning, and research purposes. Originally developed in 1991, it has been updated and enhanced since, and made available without charge from 1996 on the World Wide Web. The program, which is still being updated, has gone through a number of revisions and developments in the 16+ years since its original internet launch. During this time over 2.5 million visits have been logged at the AIDA Websites and more than 400,000 copies of the program have been downloaded. Further copies of the simulator have been made available, in the past, on diskette by the system developers and from the British Diabetic Association (BDA) — now called 'Diabetes UK' — London, England, following the BDA's own independent evaluation of the software. More than 1,075,000 diabetes simulations have been run via a web-based version of the AIDA diabetes simulator.
Colestilan is a medication that acts as a phosphate binder and bile acid sequestrant. It is an ion-exchange resin, is an orally administered bile acid sequestrant that is being developed by Mitsubishi Tanabe Pharma Corporation for the treatment of hypercholesterolaemia and hyperphosphataemia. It has been launched in Japan for hypercholesterolaemia. For the treatment of hyperphosphataemia, it is launched in Austria, Germany, the Czech Republic, Portugal and the United Kingdom, is registered in the EU. Phase III development in paediatric patients with hyperphosphataemia associated with chronic kidney disease was underway in the UK and Germany. However, the company discontinued the development. In addition, the phase II development in type-2 diabetes mellitus and phase I development in hyperphosphataemia, in Japan, was also discontinued by the company.
The European Association for the Study of Diabetes (EASD) is a scientific association founded in Montecatini Terme, Italy in 1965 with Joseph Hoet as Founding President. The aims of the association are to encourage and support research in the field of diabetes, the rapid diffusion of acquired knowledge in that field, and to facilitate its application.
The International Pharmaceutical Students' Federation (IPSF) is a non-governmental, non-political and non-religious organisation that represents pharmaceutical students, pharmacy students and recent graduates from all over the world. It was founded in 1949 and it is the oldest faculty-based student organisation. IPSF represents over 500,000 individuals in more than 100 countries with 127 different representative pharmacy student member organisations.
The Pan American Association of Anatomy (PAA) is a public, nonprofit, scientific organization that brings together professionals engaged in the study of Anatomy and related sciences in the American continent.
The European Federation of Periodontology (EFP) is a non-profit organisation dedicated to promoting awareness of periodontal science – the science and clinical practice of periodontics and implant dentistry – and the importance of gum health. Its guiding vision is “Periodontal health for a better life.”
Andrej Janež is a Slovenian diabetologist and diabetes researcher. Janež is the Head of Department of Endocrinology, Diabetes and Metabolic Disease at University Medical Centre Ljubljana, Assistant Professor for Internal Medicine at the Medical University Ljubljana, Chairman of the Advances in Diabetes and Insulin Therapy conference, member of the advisory board for peroral antidiabetic therapy in Servier Pharma, member for Slovenia in the Diabetes Education Study Group at European Association for the Study of Diabetes, and member of the European advisory board for continuous glucose monitoring system in development for Lifescan.
Bernhard Ludvik is a Specialist in Internal Medicine, board certified in Endocrinology and Metabolism. He is currently an Associate Professor of Medicine at the Medical University of Vienna. He serves as the Deputy Head of the Division of Endocrinology and Metabolism at the General Hospital Vienna.
The European Society for the History of Photography (ESHPh), founded in 1978, is a society concerned with the historical events within photography from a European perspective.
The Federation of European Pharmacological Societies (EPHAR) is a non-profit voluntary association established to advance research and education in the science of pharmacology and to promote co-operation between national/regional pharmacological societies in Europe and surrounding countries. It is an umbrella organization of currently 29 national societies for pharmacology and represents over 12,000 individual pharmacologists in Europe. Moreover it seeks to co-operate with other international organizations, especially the International Union of Basic and Clinical Pharmacology (IUPHAR) of which EPHAR is an associate member.
Stefan R. Bornstein is the director of the Centre for Internal Medicine and the Medical Clinic and Policlinic III at the University Hospital Carl Gustav Carus of the Technical University of Dresden as well as the medical faculty's vice dean of international affairs and development and a member of the supervisory board of the University Hospital of Dresden. Furthermore, he is chair and honorary consultant for diabetes and endocrinology at King's College London. Previously, Bornstein worked as assistant director and professor of endocrinology at the University Hospital of Düsseldorf, as unit chief at the National Institutes of Health in Bethesda, Maryland and held the Heisenberg-scholarship of the Deutsche Forschungsgemeinschaft.
The Hamburg Centre for Ultrafast Imaging (CUI) is a research facility established in the context of the Universities Excellence Initiative by the German Federal and State Governments. The multidisciplinary and interinstitutional cluster is located at Universität Hamburg, Hamburg, Germany, and has been initiated on 1 November 2012. The funding with more than €25 million by the German Research Foundation will run until 31. December 2018. Scientific teams cooperating in the cluster come from the Universität Hamburg, the Deutsches Elektronen-Synchrotron (DESY), the European XFEL GmbH (XFEL), the European Molecular Biology Laboratory (EMBL), and the newly founded Max-Planck-Institute for the Structure and Dynamics of Matter (MPSD). A full application for a second research period of seven years was handed in at the end of 2017 to the German Research Foundation (DFG) for discussion. After the successful application in 2018, the new cluster “CUI: Advanced Imaging of Matter” started in 2019.
Franz Loogen was a German cardiologist. He is a pioneer of cardiac catheterization and is considered the founding father of cardiology as an independent specialty of internal medicine in Germany. He held the first cardiology chair outside paediatrics in Germany and founded the so-called "Düsseldorf School of Cardiology", from which many full professors, chief physicians and practising cardiologists have emerged. He also looked after the Germany national football team at the 1954 World Cup as team doctor.
Michael Roden is Professor and Chairman of Internal Medicine, Endocrinology and Metabolic Disorders at Heinrich Heine University Düsseldorf, Director of the Division of Endocrinology and Diabetology at the University Hospital of Düsseldorf and Spokesman for the Executive Board and Scientific Director of the German Diabetes Center, the Leibniz Center for Diabetes Research at the Heinrich Heine University Düsseldorf.
The German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at Heinrich Heine University (HHU), is a research institution based in Düsseldorf. In 1964, it was founded due to the initiative of Prof. Dr. med. Karl Oberdisse as an Association for the Promotion of Research on Diabetes mellitus. The DDZ performs research on diabetes mellitus in a transdisciplinary approach. The aim is the prevention, early detection, diagnosis and treatment of diabetes and its sequelae. The work focuses on application-oriented research in the fields of clinical diabetology, clinical biochemistry and pathobiochemistry, biometrics and epidemiology, vascular and islet cell biology as well as health services research and health economics. The investigation of risk genes, mechanisms, individual lifestyles in combination with environmental influences and their long-term effects on the population and their supply play a decisive role. DDZ has also performed clinical studies and established several cohorts, such as the German Diabetes Study (GDS), which examines the course of diabetes as well as its sequelae. Since 2008, Michael Roden is the chief scientific officer and spokesman of the board of the DDZ as well as the director of the Institute for Clinical Diabetology. Additionally, he serves as the chief physician of the Division of Endocrinology and Diabetology at the University Hospital Düsseldorf.
Brian M. Frier is a Scottish physician, diabetologist, clinical scientist, and an Honorary Professor of Diabetes at the University of Edinburgh. He is best known for his many scientific contributions to the pathophysiological understanding of hypoglycemia, a common adverse effect of insulin therapy in diabetic patients whose societal impact has deserved increasing media attention worldwide. His honors include the R.D. Lawrence Lecture of the British Diabetic Association in 1986, the Banting Memorial Lecture at Diabetes UK in 2009, the Camillo Golgi Prize and lecture at the 53rd annual EASD conference in 2017, and the Michael Somogyi Award from the Hungarian Diabetes Association in 2004. Frier is a science book author and editor, and a science journal Chief editor. He is also regarded as an authority on the field of driving and diabetes. In 2023, Frier was accorded Honorary Life Membership by the European Association of Diabetes.
Gerhardt Katsch was a German internist. Between 1928 and 1957 he served as Professor of Internal medicine at the University of Greifswald. It was on the initiative of Katsch that in 1930 a residential facility providing clinical and socio-medical care for Diabetic patients was established at Garz on the Island of Rügen. It was the first institution of its kind in Germany. Gerhardt Katsch is widely regarded – alongside Oskar Minkowski and Karl Stolte – as one of the three principal pioneers of modern diabetes management in Germany.
Andrew Almon Fletcher was a Canadian physician and pioneering diabetologist, known as one of the five co-authors of the famous 1922 paper Pancreatic Extracts in the Treatment of Diabetes Mellitus.
Vijay Viswanathan is a diabetologist from India who is the chief diabetologist at M.V. Hospital for Diabetes based in Chennai. He is also the President of Prof. M. Viswanathan Diabetes Research Centre and the first Asian President of D-Foot International, a non-profit organization based in Belgium. Viswanathan has published over 543 research papers, in publications including the National Library of Medicine, on topics such as primary prevention and management of diabetes, diabetic foot and prevention of amputation, diabetic nephropathy, socio-economics of diabetes care and Pulmonary TB and diabetes.